Bausch Health Companies Investor Conference Presentation Deck
Solta Medical At-A-Glance
Key Leadership Appointments
Paul Herendeen
Chairman
9
Scott Hirsch
Chief Executive Officer
Tom Hart
Chief Operating Officer
Judah Bareli
General Counsel
To be Announced - Chief Financial Officer
Post Separation Profile
111
2017
2017-2020 Revenue
-32%
CAGR³
135
2018
thermage
FLX
YTD 2021 Organic Revenue ¹,4:
RF system
194
2019
1. See Slide 2 and Appendix for further non-GAAP information.
BAUSCH- Health 2. Excludes BHC corporate allocations and any potential standalone costs
3. Compound Annual Growth Rate.
clear+
brilliant.
touch-
253
2020
+27%
Expected Tax Rate: Mid-teens %
Domiciled: Canada; U.S. corporate
offices will be NJ
Intend to apply for listing on: NASDAQ
2017-2020 Adj. EBITDA (non-GAAP) ¹,2
clear +
brilliant.
touch laser
20
2017
fraxel
~87%
CAGR ³
48
2018
fraxel.
laser
.….....
87
2019
135
2020
$M, USD
VASERⓇ
ultrasonic system
4. Organic growth/change, a non-GAAP metric, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions,
divestitures and discontinuations.View entire presentation